Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$637M |
| 2 |
Weyerhaeuser
WY
|
+$340M |
| 3 |
IQVIA
IQV
|
+$132M |
| 4 |
Halliburton
HAL
|
+$123M |
| 5 |
Dover
DOV
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.68B |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$708M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$460M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$293M |
| 5 |
Gilead Sciences
GILD
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Healthcare | 5.12% |
| 3 | Financials | 4.53% |
| 4 | Consumer Discretionary | 4.09% |
| 5 | Communication Services | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ASRT
4751
CALL
DELISTED
Assertio
ASRT
| $116K | ﹤0.01% |
335
+250
| +294% | +$118K |
|
|
CPRX
4752
DELISTED
Catalyst Pharmaceutical
CPRX
| $116K | ﹤0.01% |
46,080
+30,001
| +187% | +$82.3K |
|
4753
PUT
Direxion Daily MSCI Emerging Markets Bull 3X ETF
EDC
$162M
| $116K | ﹤0.01% |
1,100
-1,600
| -59% | -$162K |
|
4754
MannKind Corp
MNKD
$1.31B
| $116K | ﹤0.01% |
53,567
-58,856
| -52% | -$92.3K |
|
4755
Materion
MTRN
$6.18B
| $116K | ﹤0.01% |
2,697
-2,772
| -51% | -$106K |
|
|
ATNX
4756
DELISTED
Athenex, Inc. Common Stock
ATNX
| $116K | ﹤0.01% |
+330
| New | +$112K |
|
4757
Babcock & Wilcox
BW
$1.42B
| $115K | ﹤0.01% |
3,415
+2,409
| +239% | +$148K |
|
4758
Coherus Oncology
CHRS
$224M
| $115K | ﹤0.01% |
8,639
-13,008
| -60% | -$172K |
|
4759
iShares Global Industrials ETF
EXI
$1.48B
| $115K | ﹤0.01% |
1,290
-52,336
| -98% | -$4.49M |
|
|
NEOS
4760
DELISTED
Neos Therapeutics, Inc
NEOS
| $115K | ﹤0.01% |
12,581
+6,590
| +110% | +$50.1K |
|
|
MDR
4761
PUT
DELISTED
McDermott International
MDR
| $115K | ﹤0.01% |
5,267
+4,767
| +953% | +$95.6K |
|
|
ELLI
4762
CALL
DELISTED
Ellie Mae Inc
ELLI
| $115K | ﹤0.01% |
1,400
+1,100
| +367% | +$101K |
|
|
KANG
4763
CALL
DELISTED
iKang Healthcare Group, Inc.
KANG
| $115K | ﹤0.01% |
+8,500
| New | +$114K |
|
|
SEP
4764
PUT
DELISTED
Spectra Engy Parters Lp
SEP
| $115K | ﹤0.01% |
2,600
-700
| -21% | -$31.1K |
|
|
WIN
4765
CALL
DELISTED
Windstream Holdings Inc
WIN
| $115K | ﹤0.01% |
13,020
-180
| -1% | -$2.39K |
|
|
CADE
4766
DELISTED
Cadence Bancorporation
CADE
| $115K | ﹤0.01% |
5,009
+5,002
| +71,457% | +$109K |
|
|
GOOD
4767
Gladstone Commercial Corp
GOOD
$593M
| $114K | ﹤0.01% |
5,083
+5,065
| +28,139% | +$108K |
|
4768
PUT
Insperity
NSP
$1.95B
| $114K | ﹤0.01% |
2,600
-1,800
| -41% | -$71.3K |
|
4769
PUT
Realty Income
O
$58.5B
| $114K | ﹤0.01% |
2,064
+929
| +82% | +$51.6K |
|
4770
CALL
iShares TIPS Bond ETF
TIP
$14.5B
| $114K | ﹤0.01% |
+1,000
| New | +$114K |
|
|
SAVE
4771
CALL
DELISTED
Spirit Airlines, Inc.
SAVE
| $114K | ﹤0.01% |
3,400
-10,200
| -75% | -$408K |
|
|
BOLD
4772
DELISTED
Audentes Therapeutics, Inc
BOLD
| $114K | ﹤0.01% |
4,084
+3,322
| +436% | +$72.1K |
|
4773
Amkor Technology
AMKR
$13.4B
| $113K | ﹤0.01% |
10,781
-4,651
| -30% | -$44.5K |
|
4774
St. Joe Company
JOE
$3.7B
| $113K | ﹤0.01% |
6,012
-8,518
| -59% | -$158K |
|
4775
CALL
M&T Bank
MTB
$36.4B
| $113K | ﹤0.01% |
700
+300
| +75% | +$47.1K |
|
Similar funds
Barclays's Q3 2017 Portfolio in Review
As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
- Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
- Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
- Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
- Barclays opened 424 new positions and closed 405 in Q3 2017.
- Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.
Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.